AGITG Pancreatic Cancer surgical guidelines update
Many thanks to Doctor Robert Gandy for providing this summary. The Leadership Group of the AGITG Pancreatic Cancer Surgical... Read More
A/Prof Nick Pavlakis leads the way for better treatments
Associate Professor Nick Pavlakis is used to working under pressure. As a medical oncologist specialising in Gastro-Intestinal (GI)... Read More
Remembering a life cut short by a little-known cancer
Michelle met Bill for the first time in her own backyard. She was living with a friend, who... Read More
Professor Niall Tebbutt, Inaugural AGITG Fundraiser of the Year
Professor Niall Tebbutt became the first AGITG member to be awarded the AGITG Fundraiser of the Year Award... Read More
Life as a medical oncologist during COVID-19
Associate Professor Lara Lipton is a medical oncologist working in Melbourne. We spoke to her about the impact... Read More
Associate Professor Jeanne Tie on receiving the Best New Concept Award
Medical oncologist Associate Professor Jeanne Tie was awarded the Best New Concept Award at the New Concepts Symposium... Read More
AGITG Trial updates: October 2020
FORECAST-1 The FORECAST-1 trial investigating personalised treatments for advanced colorectal cancer has opened and the first two patients have joined the study. There is a large unmet need for people with metastatic colorectal cancer when standard therapy fails. Professor Peter Gibbs and his team are addressing this by using new technology to... Read More
The Consumer Advisory Panel welcomes two new members
Two new members have joined our Consumer Advisory Panel this year – oesophageal cancer survivor Geoff Parnell, and... Read More
Pancreatic cancer study is RANDOMS by name, but not by nature
Although the study dietitian Belinda Steer has developed is called RANDOMS, its impact will be anything but random.... Read More
In FORECAST-1, organoid technology predicts the best colorectal cancer treatment
There is a large unmet need for people with metastatic colorectal cancer when standard therapy fails. Professor Peter... Read More